{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:58:01Z","timestamp":1781308681338,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008331","name":"Federal University of Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128483","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:41:39Z","timestamp":1773819699000},"page":"128483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Long-term persistence of Seroprotection following a modified hepatitis B vaccine schedule in people living with HIV"],"prefix":"10.1016","volume":"79","author":[{"given":"C.S.","family":"Troccoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.B.","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.V.","family":"Potsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128483_bb0005","series-title":"Recommendations for hepatitis B prevention in people with HIV. Atlanta (GA)","author":"Centers for Disease Control and Prevention","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128483_bb0010","author":"European AIDS Clinical Society"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128483_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2016.1277844","article-title":"Hepatitis B virus vaccination in HIV-infected people: a review","volume":"13","author":"Catherine","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128483_bb0020","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1473-3099(12)70243-8","article-title":"Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1","volume":"12","author":"Whitaker","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"41","key":"10.1016\/j.vaccine.2026.128483_bb0025","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1016\/j.vaccine.2012.07.028","article-title":"Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults","volume":"30","author":"Potsch","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128483_bb0030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jamainternmed.2016.0741","article-title":"Long-term immune response to hepatitis B virus vaccination regimens in adults with human immunodeficiency virus 1: secondary analysis of a randomized clinical trial","volume":"176","author":"Launay","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"27","key":"10.1016\/j.vaccine.2026.128483_bb0035","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.vaccine.2021.05.044","article-title":"Immunogenicity and persistence of high-dose recombinant hepatitis B vaccine in adults infected with human immunodeficiency virus in China: a randomized, double-blind, parallel controlled trial","volume":"39","author":"Feng","year":"2021","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2026.128483_bb0040","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1016\/j.vaccine.2017.06.040","article-title":"Long-term protection after hepatitis B vaccination in people living with HIV","volume":"35","author":"Lara","year":"2017","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128483_bb0045","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1089\/aid.2017.0070","article-title":"Hepatitis B virus vaccination in HIV: immunogenicity and persistence of seroprotection up to 7 years following a primary immunization course","volume":"34","author":"Nicolini","year":"2018","journal-title":"AIDS Res Hum Retrovir"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128483_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12981-019-0249-8","article-title":"Higher rate of long-term serologic response of four double doses vs standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomized controlled trial","volume":"16","author":"Chaiwarith","year":"2019","journal-title":"AIDS Res Ther"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128483_bb0055","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.vaccine.2009.11.045","article-title":"Persistence of vaccine immunity against hepatitis B virus and response to revaccination in vertically HIV-infected adolescents on HAART","volume":"28","author":"Pessoa","year":"2010","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128483_bb0060","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/infdis\/jis243","article-title":"The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection?","volume":"205","author":"Powis","year":"2012","journal-title":"J Infect Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2026.128483_bb0065","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1016\/j.vaccine.2011.03.077","article-title":"Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy","volume":"29","author":"Lao-Araya","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128483_bb0070","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/hep.32474","article-title":"Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose","volume":"76","author":"Bruce","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128483_bb0075","article-title":"Persistence of immunity in adults after 1, 5 and 10 years with recombinant hepatitis B vaccine in Beijing in 2010\u20132020","volume":"10","author":"Shen","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128483_bb0080","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/jvh.13125","article-title":"Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults","volume":"26","author":"Van Damme","year":"2019","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128483_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192638","article-title":"Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults","volume":"13","author":"Giacomet","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128483_bb0090","series-title":"National Immunization Program: National vaccination schedule 2020","author":"Brazil. Ministry of Health","year":"2020"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:53:50Z","timestamp":1781308430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26002914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":18,"alternative-id":["S0264410X26002914"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128483","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term persistence of Seroprotection following a modified hepatitis B vaccine schedule in people living with HIV","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128483"}}